Bispecific antibody News and Research

RSS
Novel antibody candidate shows potent binding to diverse SARS-CoV-2 variant mutations

Novel antibody candidate shows potent binding to diverse SARS-CoV-2 variant mutations

NK cells combined with bispecific antibody display potent anti-tumor activity against lymphoma cells

NK cells combined with bispecific antibody display potent anti-tumor activity against lymphoma cells

Studies reveal the promise of newly engineered bispecific antibodies against tumor cells

Studies reveal the promise of newly engineered bispecific antibodies against tumor cells

Researchers develop mutant gene-targeted immunotherapy approach to fight cancers

Researchers develop mutant gene-targeted immunotherapy approach to fight cancers

Study reveals how cancer cells escape death by lymphocytes

Study reveals how cancer cells escape death by lymphocytes

Nanobodies protect against SARS-CoV-2 variants in animal model

Nanobodies protect against SARS-CoV-2 variants in animal model

Bispecific antibody shows efficacy against new SARS-CoV-2 variants

Bispecific antibody shows efficacy against new SARS-CoV-2 variants

Second-generation double antibody protects from SARS-CoV-2 and its tested variants

Second-generation double antibody protects from SARS-CoV-2 and its tested variants

MD Anderson and Xencor to develop novel antibody therapeutics to treat cancer patients

MD Anderson and Xencor to develop novel antibody therapeutics to treat cancer patients

Challenges in High Complexity Flow Cytometry

Challenges in High Complexity Flow Cytometry

Airway and Celonic collaborate to produce AT-100 as therapeutic candidate against COVID-19

Airway and Celonic collaborate to produce AT-100 as therapeutic candidate against COVID-19

FDA gives clearance to IND application for Calibr's 'switchable' CAR-T cell therapy

FDA gives clearance to IND application for Calibr's 'switchable' CAR-T cell therapy

Turbine appoints new SAB members to guide its simulation-first drug discovery mission

Turbine appoints new SAB members to guide its simulation-first drug discovery mission

IONTAS antibody for the treatment of B-Cell ALL receives approval for clinical trials

IONTAS antibody for the treatment of B-Cell ALL receives approval for clinical trials

Chemotherapy can cause drug-resistant mutations in pediatric ALL patients who relapse

Chemotherapy can cause drug-resistant mutations in pediatric ALL patients who relapse

AbbVie, Teneobio enter into strategic transaction to develop potential treatment for multiple myeloma

AbbVie, Teneobio enter into strategic transaction to develop potential treatment for multiple myeloma

Integral Molecular and Merus collaborate to develop bispecific antibody therapeutics

Integral Molecular and Merus collaborate to develop bispecific antibody therapeutics

ESMO Immuno-Oncology Congress showcases novel technologies set to benefit many cancer patients

ESMO Immuno-Oncology Congress showcases novel technologies set to benefit many cancer patients

Scientists equip new virus that kills carcinoma cells with protein

Scientists equip new virus that kills carcinoma cells with protein

VTT, Dyadic to present data highlighting achievements in development of fungal production platform

VTT, Dyadic to present data highlighting achievements in development of fungal production platform